​​​​​​​Pharma has heard enough of New York Governor Andrew Cuomo’s ideas to lower drug prices, and it's lobbying state officials to oppose it, too.

Pfizer CEO Ian Read says he is “enthusiastic” about some of the potential changes President Trump is proposing for healthcare, like tax reform and regulatory…

Biogen says it received a subpoena from the feds in December relating to rebate payments and Biogen's co-pay assistance programs for Tecfidera and other…

After a string of setbacks, Bristol-Myers Squibb was badly in need of some good news on the immuno-oncology front, and Thursday, that’s what it got.

Pharma CEOs got marching orders from President Trump on Tuesday morning: Lower "astronomical" prices, give us "better innovation" and make…

Allergan, Merck, Novartis and Eli Lilly so far are the only Big Pharmas to speak on President Trump's executive order blocking citizens of seven Muslim-…

Johnson & Johnson CEO Alex Gorsky said there are aspects of the ACA that can help patients and lower costs for the country and should be maintained.

​​​​​​​AstraZeneca’s aging respiratory giant Symbicort won a coveted pediatric exclusivity nod from the FDA, putting it in line for hundreds of millions in…

A top U.S. health official says there’s no settlement with Mylan, adding yet another twist to the company’s prolonged EpiPen episode.

Regulatory